Plain-English translation of NCT05574673 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →This is an observational study — meaning researchers will follow you over time rather than test a new medication. The study aims to understand the genetic makeup of ovarian cancer by looking at specific gene mutations (BRCA1 and BRCA2) and other patterns in cancer cells. By studying how patients with different genetic profiles respond to standard chemotherapy, researchers hope to better predict which treatments will work best for each person.
Ovarian cancer is not one-size-fits-all — some patients respond very well to treatment while others don't. This study exists to identify the genetic and biological markers that predict who will have long-lasting benefit from treatment and who may need different approaches sooner.
You likely qualify if…
You likely don't qualify if…
You will be followed by the research team at your cancer center from the time of your diagnosis through your first round of chemotherapy and beyond. Researchers will collect information about your treatment response at regular visits and will ask you to provide a tissue sample from your tumor. The study will track you for up to 5 years after your initial response assessment, monitoring how well you respond to treatment and collecting clinical data along the way. No experimental medication is being tested — this study simply observes and documents your standard cancer treatment and outcomes.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Denmark
Sponsor
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Enrollment target
~1,000 participants
Started
December 2022
Primary completion
May 2028
Age range
18 Years – 100 Years
Sex
Female only
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kristine Madsen, MD
NSGO-CTU
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.